KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Merck (MRK) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to 16.73%.

  • Merck's EBIT Margin rose 166700.0% to 16.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 11.14%, marking a year-over-year increase of 136100.0%. This contributed to the annual value of 7.39% for FY2024, which is 310700.0% up from last year.
  • Latest data reveals that Merck reported EBIT Margin of 16.73% as of Q3 2025, which was up 166700.0% from 9.12% recorded in Q2 2025.
  • Over the past 5 years, Merck's EBIT Margin peaked at 16.73% during Q3 2025, and registered a low of 62.25% during Q2 2023.
  • In the last 5 years, Merck's EBIT Margin had a median value of 0.26% in 2021 and averaged 1.65%.
  • As far as peak fluctuations go, Merck's EBIT Margin tumbled by -641100bps in 2023, and later surged by 762800bps in 2024.
  • Merck's EBIT Margin (Quarter) stood at 0.26% in 2021, then tumbled by -1128bps to 2.66% in 2022, then plummeted by -1430bps to 40.72% in 2023, then skyrocketed by 105bps to 2.19% in 2024, then skyrocketed by 664bps to 16.73% in 2025.
  • Its EBIT Margin stands at 16.73% for Q3 2025, versus 9.12% for Q2 2025 and 16.0% for Q1 2025.